BioNTech SE - ADR vs Taiwan Semiconductor Mfg. Co. Ltd. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Taiwan Semiconductor Mfg. Co. Ltd. trades at $428.2 (market cap $1.93T). The key difference: Taiwan Semiconductor Mfg. Co. Ltd. is far larger — about 82.8× BioNTech SE - ADR's market cap, and Taiwan Semiconductor Mfg. Co. Ltd. pays a 0.9% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | TSM | |
|---|---|---|
Market Cap | $23.31B | $1.93T |
Sector | Health | Technology |
52-Week High | $119.34 | $477.57 |
52-Week Low | $83.89 | $227.33 |
Enterprise Value | $6.60B | $1.85T |
Dividend Yield | — | 0.9% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Taiwan Semiconductor Manufacturing Company, or TSMC, is the world's largest dedicated chip foundry, with over 57% market share in 2021 per Gartner. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the U.S. in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs.
Read more on TSM →